Vito Andrea Capozzi, Alessandra De Finis, Elisa Scarpelli, A Gallinelli, Luciano Monfardini, Stefano Cianci, Ferdinando Antonio Gulino, Isabella Rotondella, Gabriella Maria Celora, Giulia Martignon, Tullio Ghi, Roberto Berretta,
Minimally Invasive Surgery (MIS) represents a safe and feasible option for the surgical treatment of gynecologic malignancies, offering benefits, including reduced blood loss, lower complications, and faster recovery, without compromising oncological outcomes in selected patients. MIS is widely accepted in early-stage gynecologic malignancies, including endometrial cancer, cervical tumors measuring 2 cm or less, and early-stage ovarian cancer, considering the risk of surgical spillage. Despite its ...
Tópico(s): Colorectal Cancer Surgical Treatments
2024 - Multidisciplinary Digital Publishing Institute | Journal of Personalized Medicine